Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Treatment protocols for renal cell cancer

Tim Brenner, PharmD, BCOP
Shrina Duggal, PharmD, BCOP
Jim Natale, PharmD, BCOP
Scott M Wirth, PharmD, BCOP
Section Editor
John W Mucenski, PharmD
Deputy Editor
Michael E Ross, MD


The following material represents a subset of chemotherapy regimens that are used for the treatment of patients with advanced renal cell cancer. This is not an exhaustive list. Additional regimens may be added over time, particularly as treatment for renal cell cancer evolves.

This topic review does not address the appropriate context for use of these regimens in the care of patients with renal cell cancer. Clinicians should refer to the individual disease-oriented topic reviews that discuss the use of these protocols in appropriate clinical situations:

These tables are provided as examples of how to administer these regimens; there may be other acceptable methods. All protocols must be administered by clinicians who are trained in the use of chemotherapy. The clinician is expected to use his or her independent medical judgment in the context of individual circumstances to make adjustments, as necessary.


Advanced or metastatic renal cell carcinoma

Temsirolimus — (table 1)

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information on subscription options, click below on the option that best describes you:

Subscribers log in here

Literature review current through: Nov 2017. | This topic last updated: Sep 13, 2016.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2017 UpToDate, Inc.